Porto, Portugal
+351 960 245 977
fbnsantos@fbnsantos.com

Category: BRCA genes

Robotics | IoT

CRISPR Dispute Raises Bigger Patent Issues That We’re Not Talking About

The worlds of science, technology and patent law eagerly await the U.S. government’s decision on who deserves patents on what many have referred to as the biotechnology invention of the century: the CRISPR/Cas9 gene-editing technique. Scientists hail CRISPR/Cas9 as more accurate and efficient than other, now-traditional genetic engineering methods. As a result, CRISPR has generated worldwide debate about how it could accelerate the manipulation of plants, animals and even human beings at the molecular level. That some DNA modifications can be passed on to future generations raises particular concern. But the patent dispute, focusing on whether scientists at the Broad… read more